Potential for global elimination of cervical cancer: modelled projections of the impact of scaled-up HPV vaccination and cervical screening in 181 countries from 2020 to 2099

A new study by researchers from the International Agency for Research on Cancer (IARC) and partners, published today in The Lancet Oncology, quantifies the cumulative potential impact of scaled-up global HPV vaccination and cervical screening coverage on cervical cancer cases averted over the 50 years from 2020 to 2069, and predicts outcomes beyond 2070 in order to identify the earliest years by which cervical cancer rates could drop below levels that could be considered as elimination thresholds.

Simms KT, Steinberg J, Caruana M, Smith MA, Lew JB, Soerjomataram I, et al.
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
Lancet Oncol, Published online 19 February 2019;
https://doi.org/10.1016/S1470-2045(18)30836-2

Read the article

Read IARC Press Release 266